273 related articles for article (PubMed ID: 17413764)
21. Biomarkers and coagulation tests for assessing the biosimilarity of a generic low-molecular-weight heparin: results of a study in healthy subjects with enoxaparin.
Kuczka K; Harder S; Picard-Willems B; Warnke A; Donath F; Bianchini P; Parma B; Blume H
J Clin Pharmacol; 2008 Oct; 48(10):1189-96. PubMed ID: 18716314
[TBL] [Abstract][Full Text] [Related]
22. Thrombin-activated thrombelastography for evaluation of thrombin interaction with thrombin inhibitors.
Taketomi T; Szlam F; Vinten-Johansen J; Levy JH; Tanaka KA
Blood Coagul Fibrinolysis; 2007 Dec; 18(8):761-7. PubMed ID: 17982317
[TBL] [Abstract][Full Text] [Related]
23. Determination of antithrombin-dependent factor Xa inhibitors by prothrombin-induced clotting time.
Harenberg J; Giese C; Hagedorn A; Traeger I; Fenyvesi T
Semin Thromb Hemost; 2007 Jul; 33(5):503-7. PubMed ID: 17629847
[TBL] [Abstract][Full Text] [Related]
24. The inhibitory effect of recombinant human soluble thrombomodulin on initiation and extension of coagulation--a comparison with other anticoagulants.
Mohri M; Sugimoto E; Sata M; Asano T
Thromb Haemost; 1999 Dec; 82(6):1687-93. PubMed ID: 10613656
[TBL] [Abstract][Full Text] [Related]
25. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
Raivio P; Kuitunen A; Petäjä J; Ilveskero S; Lassila R
Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
[TBL] [Abstract][Full Text] [Related]
26. Rivaroxaban demonstrates in vitro anticoagulant effects in canine plasma.
Conversy B; Blais MC; Dunn M; Gara-Boivin C; Carioto L; del Castillo JR
Vet J; 2013 Nov; 198(2):437-43. PubMed ID: 24053991
[TBL] [Abstract][Full Text] [Related]
27. Anticoagulant property of a semi-synthesized sodium beta-1,4-glucan sulfate.
Wang ZM; Li L; Li B; Guo SY
Yao Xue Xue Bao; 2006 Apr; 41(4):323-7. PubMed ID: 16856476
[TBL] [Abstract][Full Text] [Related]
28. From selective substrate analogue factor Xa inhibitors to dual inhibitors of thrombin and factor Xa. Part 3.
Dönnecke D; Schweinitz A; Stürzebecher A; Steinmetzer P; Schuster M; Stürzebecher U; Nicklisch S; Stürzebecher J; Steinmetzer T
Bioorg Med Chem Lett; 2007 Jun; 17(12):3322-9. PubMed ID: 17462889
[TBL] [Abstract][Full Text] [Related]
29. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
Melo FR; Mourão PA
Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
[TBL] [Abstract][Full Text] [Related]
30. Effects of tannins from Geum japonicum on the catalytic activity of thrombin and factor Xa of blood coagulation cascade.
Dong H; Chen SX; Kini RM; Xu HX
J Nat Prod; 1998 Nov; 61(11):1356-60. PubMed ID: 9834152
[TBL] [Abstract][Full Text] [Related]
31. Influence of coagulation factors on intrinsic thrombin generation.
Stief TW; Otto S; Renz H
Blood Coagul Fibrinolysis; 2007 Jan; 18(1):67-71. PubMed ID: 17179830
[TBL] [Abstract][Full Text] [Related]
32. Anticoagulant action of rare earth metals.
Funakoshi T; Furushima K; Shimada H; Kojima S
Biochem Int; 1992 Oct; 28(1):113-9. PubMed ID: 1445385
[TBL] [Abstract][Full Text] [Related]
33. [Anticoagulant activity of low-molecular-weight heparins obtained using a hydrolase complex].
Drozd NN; Tolstenkov AS; Bannikova GE; Miftakhova NT; Lapikova ES; Makarov VA; Varlamov VP
Eksp Klin Farmakol; 2007; 70(6):19-24. PubMed ID: 18318190
[TBL] [Abstract][Full Text] [Related]
34. [Anticoagulant effect of phosphatidylserine].
Tersenov OA; Chabanov MK
Vopr Med Khim; 1981; 27(5):619-23. PubMed ID: 7314577
[TBL] [Abstract][Full Text] [Related]
35. Novel anticoagulants based on direct inhibition of thrombin and factor Xa.
Gardell SJ; Sanderson PE
Coron Artery Dis; 1998; 9(2-3):75-81. PubMed ID: 9647407
[No Abstract] [Full Text] [Related]
36. Recombinant Kunitz protease inhibitory domain of the amyloid beta-protein precursor as an anticoagulant in venovenous extracorporeal circulation in rabbits.
Annich G; White T; Damm D; Zhao Y; Mahdi F; Meinhardt J; Rebello S; Lucchesi B; Bartlett RH; Schmaier AH
Thromb Haemost; 1999 Nov; 82(5):1474-81. PubMed ID: 10595641
[TBL] [Abstract][Full Text] [Related]
37. Arginine inhibits serpins.
Stief TW
Clin Appl Thromb Hemost; 2007 Apr; 13(2):213-8. PubMed ID: 17456633
[TBL] [Abstract][Full Text] [Related]
38. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
[TBL] [Abstract][Full Text] [Related]
39. Purification and partial characterization of draculin, the anticoagulant factor present in the saliva of vampire bats (Desmodus rotundus).
Apitz-Castro R; Béguin S; Tablante A; Bartoli F; Holt JC; Hemker HC
Thromb Haemost; 1995 Jan; 73(1):94-100. PubMed ID: 7740503
[TBL] [Abstract][Full Text] [Related]
40. Thrombin generation by hemolysis.
Stief TW
Blood Coagul Fibrinolysis; 2007 Jan; 18(1):61-6. PubMed ID: 17179829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
